Clinical Trials Logo
  1. Home
  2. Neoplasms
  3. NCT01255748
  4. Details
NCT01255748 Clinical Trial

Registry Study for Radiation Therapy Outcomes

Neoplasms Clinical Trial

Official title:
Evaluation Tracking Project: A Prospective Chart Review of Patients Treated With Radiation Therapy

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT01255748
Other study ID # REG001-09
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 2009

Study information
Verified date May 2024
Source Proton Collaborative Group
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The purpose of this research study is to collect and analyze information from patients being treated with various forms of radiation therapy.

Recruitment information / eligibility
Status Recruiting
Enrollment 40000
Est. completion date
Est. primary completion date June 2039
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Planned treatment with radiation therapy - Ability to understand and sign IRB approved consent

Study Design

Related Conditions & MeSH terms

Intervention

Radiation:
• Proton Therapy, Photon Therapy, SRS, Brachytherapy
Outcomes Tracking

Locations
Country Name City State
United States Emory Proton Therapy Center Atlanta Georgia
United States Maryland Proton Treatment Center Baltimore Maryland
United States University of Cincinnati Medical Center Cincinnati Ohio
United States South Florida Proton Therapy Institute Delray Beach Florida
United States Inova Schar Cancer Institute Fairfax Virginia
United States McLaren Proton Therapy Center Flint Michigan
United States Tennessee Oncology Proton Center Franklin Tennessee
United States Hampton University Proton Therapy Institute Hampton Virginia
United States Ackerman Cancer Center Jacksonville Florida
United States University of Kansas Proton Therapy Center Kansas City Kansas
United States Thompson Proton Center Knoxville Tennessee
United States Miami Cancer Institute Miami Florida
United States New York Proton Center New York New York
United States Oklahoma Proton Center Oklahoma City Oklahoma
United States Orlando Health Cancer Institute Orlando Florida
United States Kansas City Proton Institute Overland Park Kansas
United States Washington University in St. Louis Saint Louis Missouri
United States California Protons Cancer Therapy Center San Diego California
United States Mayo Clinic Scottsdale Arizona
United States University of Washington Seattle Washington
United States Willis-Knighton Cancer and Proton Therapy Center Shreveport Louisiana
United States ProCure Proton Therapy Center Somerset New Jersey
United States Northwestern Medicine Chicago Proton Center Warrenville Illinois

Sponsors (1)
Lead Sponsor Collaborator
Proton Collaborative Group

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Define outcomes for patients treated at participating institutions PRN
Secondary Determine strategies necessary to improve patients outcome and decrease toxicities related to treatments and procedures Annually PRN
Secondary Improve patient care by an adequate understanding of the results and patient population at participating institutions Reviewed Annually PRN
See also
  Status Clinical Trial Phase
Completed NCT03826043 - THrombo-Embolic Event in Onco-hematology N/A
Terminated NCT03166631 - A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread Phase 1
Completed NCT01938846 - BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumors Phase 1
Recruiting NCT06058312 - Individual Food Preferences for the Mediterranean Diet in Cancer Patients N/A
Completed NCT03308942 - Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants Phase 2
Recruiting NCT06018311 - Exercising Together for Hispanic Prostate Cancer Survivor-Caregiver Dyads N/A
Withdrawn NCT05431439 - Omics of Cancer: OncoGenomics
Completed NCT01343043 - A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma Phase 1
Completed NCT01938638 - Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced Cancer Phase 1
Recruiting NCT05514444 - Study of MK-4464 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors (MK-4464-001) Phase 1
Recruiting NCT02292641 - Beyond TME Origins N/A
Terminated NCT00954512 - Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004) Phase 1/Phase 2
Recruiting NCT04958239 - A Study to Test Different Doses of BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) Phase 1
Recruiting NCT04627376 - Multimodal Program for Cancer Related Cachexia Prevention N/A
Completed NCT01222728 - Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients
Recruiting NCT06004440 - Real World Registry for Use of the Ion Endoluminal System
Active, not recruiting NCT05636696 - COMPANION: A Couple Intervention Targeting Cancer-related Fatigue N/A
Not yet recruiting NCT06035549 - Resilience in East Asian Immigrants for Advance Care Planning Discussions N/A
Recruiting NCT06004466 - Noninvasive Internal Jugular Venous Oximetry
Not yet recruiting NCT02806557 - Profiling Neutrophil Counts in Patients on Chemotherapy N/A

External Links